The latest financial statement is for the quarter ending 2025-09-27.
| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net income | 14,064 | 32,218 |
| Depreciation and amortization | 2,599 | 5,211 |
| Amortization of deferred debt issuance costs | 1,493 | 3,350 |
| Reduction in carrying amount of operating lease right of use assets | 4,527 | 8,704 |
| Non-cash share-based compensation | 4,960 | 16,155 |
| Loss on disposal or impairment of licenses, property and equipment, and software | -402 | -319 |
| Fair value adjustments on interest rate derivatives | -6,154 | -17,580 |
| Loss on debt extinguishment | -5,862 | - |
| Deferred income taxes | 0 | 607 |
| Patient accounts receivable | -6,017 | 31,033 |
| Prepaid expenses | -4,064 | -1,490 |
| Other current and long-term assets | 11,511 | 3,813 |
| Accounts payable and other accrued liabilities | -19,434 | 8,191 |
| Accrued payroll and employee benefits | 17,385 | 111 |
| Insurance reserves | 4,285 | -4,929 |
| Operating lease liabilities | -5,044 | -9,479 |
| Other current and long-term liabilities | 2,623 | 1,745 |
| Net cash provided by operating activities | 33,200 | 42,937 |
| Acquisitions of businesses, net of cash acquired | 0 | 14,853 |
| Purchases of property and equipment, and software | 2,019 | 3,477 |
| Net cash used in investing activities | -2,019 | -18,330 |
| Payments for shares withheld to cover employee taxes on vesting of restricted stock | 0 | 6,292 |
| Proceeds from employee stock purchase plan | 2,152 | 1,791 |
| Proceeds from securitization obligation | 0 | 0 |
| Repayment of securitization obligation | 3,750 | 0 |
| Proceeds from issuance of term loans, net of debt issuance costs | 1,317,743 | - |
| Principal payments on term loans | 1,300,950 | 4,600 |
| Principal payments on notes payable | 1,768 | 4,086 |
| Principal payments on financing lease obligations | 0 | 0 |
| Payment of debt issuance costs | 2,506 | 1,114 |
| Settlements with interest rate swap counterparties | -3,026 | -6,144 |
| Net cash provided by financing activities | 13,947 | -8,157 |
| Net change in cash and cash equivalents | 45,128 | 16,450 |
| Cash and cash equivalents at beginning of period | 84,288 | - |
| Cash and cash equivalents at end of period | 145,866 | - |
Aveanna Healthcare Holdings, Inc. (AVAH)
Aveanna Healthcare Holdings, Inc. (AVAH)